Journal publications by FDA oncology medical reviewers

The Oncology Center of Excellence supports a robust publications program that assists FDA oncology/hematology staff in other centers to conceptualize and write manuscripts for publication in leading peer-reviewed scientific journals.

Oncology reviewers from the Office of Oncologic Diseases, working with clinical pharmacology, toxicology, and statistical reviewers, write summaries of many cancer drug approvals. FDA oncology staff also are encouraged to develop research articles and perspectives on important topics in cancer drug development, often in collaboration with academic and regulatory experts outside of FDA and internationally. The OCE Communications Program supports authors with editing and administrative publication services.

Following are publications by or with the participation of FDA oncology/hematology staff.